Duke | GenomeWeb

Duke

Maybe Next Time

Robert Cook-Deegan and Subhashini Chandrasekharan discuss genetic testing patents in the New England Journal of Medicine.

Researchers screened cancer cell lines to detect mutations and drug combinations that might sensitize tumors to drugs that impair anti-apoptosis proteins.

The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.

By overlaying epilepsy genetic data onto co-expressed gene networks from post-mortem brain samples, researchers proposed a 320-gene expression network for epilepsy.

Allen Roses Dies

Duke University's Allen Roses, known for his Alzheimer's disease research and more, has died.

Experts led by Duke neuroscientist Allen Roses developed the database hoping to boost researchers' ability to explore the role of short structural variants in complex diseases. 

Results from a study have spurred a new prospective trial comparing arrays, sequencing, and several single-marker assays in men receiving hormonal therapies.

Duke's Troubles

A whistleblower's suit against the university could force it to return hundreds of millions of dollars in grant money to the government.

A new study suggests CRISPR/Cas9-based gene activation can manipulate particular epigenomic patterns found in differentiated cells. 

Transcriptional response of pro-inflammatory and antiviral genes in the face of childhood trauma is linked to PTSD but can be mitigated.

Pages

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.